MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
65 hedge funds and large institutions have $210M invested in Marinus Pharmaceuticals, Inc in 2017 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
65
Holding in Top 10
2
Calls
$2.25M
Puts
$1.3M
Top Buyers
1 | +$8.89M | |
2 | +$8.26M | |
3 | +$8.17M | |
4 |
Citadel Advisors
Miami,
Florida
|
+$7.92M |
5 |
6CM
683 Capital Management
New York
|
+$4.49M |
Top Sellers
1 | -$21.3M | |
2 | -$7.95M | |
3 | -$4.45M | |
4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$3.31M |
5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.25M |